Evidence map›Paper›PMID 26426406›Full record

ArticleJAMA oncology2016

Failure of Ovarian Suppression With Gonadotropin-Releasing Hormone Analogs to Preserve Fertility: An Assessment Based on the Quality of Evidence.

Kutluk Oktay, Volkan Turan

Abstract readComment
PubMed Publisher
In one paragraph

Article in JAMA oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Fertility preservation in breast cancer with case-based examples for guidance.Journal of assisted reproduction and genetics · 2020
    Review
  5. Review
  6. Review
  7. Review
  8. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?Annals of oncology : official journal of the European Society for Medical Oncology · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kutluk OktayDivision of Reproductive Medicine and Laboratory of Molecular Reproduction & Fertility Preservation, Department of Obstetrics and Gynecology, New York Medical College, Valhalla2Innovation Institute for Fertility Preservation and IVF, New York, New York.
Volkan TuranDivision of Reproductive Medicine and Laboratory of Molecular Reproduction & Fertility Preservation, Department of Obstetrics and Gynecology, New York Medical College, Valhalla2Innovation Institute for Fertility Preservation and IVF, New York, New York.

Funding

Characterization & Prevention of Chemotherapy-Induced Damage to Ovarian ReserveR01HD053112 · NICHD · YALE UNIVERSITY · PI KUTLUK H OKTAY · 2007 to 2026
$7.6M
NICHD NIH HHS R01 HD053112
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PremenopauseAntineoplastic AgentsBreast NeoplasmsFemaleFertilityFertility Agents, FemaleFertility PreservationHumansInfertility, FemaleOvaryPregnancyReceptors, LHRHAntineoplastic AgentsFertility Agents, FemaleReceptors, LHRH

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.